In our study, RIG-I, but not MDA5 and TLR3, was significantly increased by Dac treatment, suggesting that RIG-I is the predominant PRR in sensing Dac in MYCN non-amplification NB cells. This evidence concerns the gene RIGI and neuroblastoma.